@SirohiBhawna @TumorBoardTues @GauravGangwan15 @DrSrinivas_C @KarynAGoodman @deepaliamit @oncologician @OncoAlert @ecancer @pashtoonkasi @GuardantHealth @anu_iris @aparna1024 @doctorC369 @Shaheenah1 #TumorBoardTuesday I am placing my hope on chemotherapy
@scserendipity1 @gabe_a_brooks The uncertainty of ATM is narrated here. 🧵 & @MCT_AACR @AACR 📝. This is also the reason ATM is not even included in the exploratory cohorts of some of the ongoing PARP⛔️trials. Anecdotally too I’ve had a few germline AT
@gabe_a_brooks Also here: https://t.co/udYBfIyvU3 I do not think I would offer immunotherapy at this point - not enough evidence of benefit
RT @MPishvaian: @TumorBoardTues @ASCO #TumorBoardTuesday Thursday Case 🎀 Then we discussed ATM💥 ➡️Pathogenic muts in ~6% of PDACs ✳️2%…
RT @MPishvaian: @TumorBoardTues @ASCO #TumorBoardTuesday Thursday Case 🎀 Then we discussed ATM💥 ➡️Pathogenic muts in ~6% of PDACs ✳️2%…
@TumorBoardTues @ASCO #TumorBoardTuesday Thursday Case 🎀 Then we discussed ATM💥 ➡️Pathogenic muts in ~6% of PDACs ✳️2% are germline ➡️Genomic scars of ATM mut PDAC - NOT the same as for BRCA ✳️@ASCO #GI21 Abs 396, Sheron Perera ➡️So PARPinh may o
RT @MPishvaian: @TumorBoardTues #TumorBoardTuesday-4/7 🧑🎓Mini-Tweetorial 1 💡Tumor somatic NGS 🧬 ➡️ “Actionable Mutations” in 25% of PDAC…
RT @MPishvaian: @TumorBoardTues #TumorBoardTuesday-4/7 🧑🎓Mini-Tweetorial 1 💡Tumor somatic NGS 🧬 ➡️ “Actionable Mutations” in 25% of PDAC…
RT @MPishvaian: @TumorBoardTues #TumorBoardTuesday-4/7 🧑🎓Mini-Tweetorial 1 💡Tumor somatic NGS 🧬 ➡️ “Actionable Mutations” in 25% of PDAC…
RT @pashtoonkasi: @MPishvaian @TumorBoardTues The uncertainty of #ATM narrated 📝 @MCT_AACR. https://t.co/JkLnlgqwMl 💭 From multiple repor…
@MPishvaian @TumorBoardTues The uncertainty of #ATM narrated 📝 @MCT_AACR. https://t.co/JkLnlgqwMl 💭 From multiple reports & discussions is the reason why ATM was excluded from the list of actionable 🧬eligible for example for this LODESTAR PARP⛔️agnos
RT @MPishvaian: @TumorBoardTues #TumorBoardTuesday-4/7 🧑🎓Mini-Tweetorial 1 💡Tumor somatic NGS 🧬 ➡️ “Actionable Mutations” in 25% of PDAC…
RT @MPishvaian: @TumorBoardTues #TumorBoardTuesday-4/7 🧑🎓Mini-Tweetorial 1 💡Tumor somatic NGS 🧬 ➡️ “Actionable Mutations” in 25% of PDAC…
RT @MPishvaian: @TumorBoardTues #TumorBoardTuesday-4/7 🧑🎓Mini-Tweetorial 1 💡Tumor somatic NGS 🧬 ➡️ “Actionable Mutations” in 25% of PDAC…
RT @MPishvaian: @TumorBoardTues #TumorBoardTuesday-4/7 🧑🎓Mini-Tweetorial 1 💡Tumor somatic NGS 🧬 ➡️ “Actionable Mutations” in 25% of PDAC…
RT @MPishvaian: @TumorBoardTues #TumorBoardTuesday-4/7 🧑🎓Mini-Tweetorial 1 💡Tumor somatic NGS 🧬 ➡️ “Actionable Mutations” in 25% of PDAC…
@TumorBoardTues #TumorBoardTuesday-4/7 🧑🎓Mini-Tweetorial 1 💡Tumor somatic NGS 🧬 ➡️ “Actionable Mutations” in 25% of PDACs https://t.co/WHbm0tWILS 💡ATM ➡️ most common actionable mutation-6.2% https://t.co/yF1vEKIevl 💡2% of PDAC pts harbor a germline
#ReviewArticle: ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications #PancreaticCancer. https://t.co/ZRl8eY8HFO https://t.co/O4It7g680s
#ReviewArticle: ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications. #PancreaticCancer https://t.co/S89bvSd50q https://t.co/UEWlit7KlM
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
Disruption of ATM signaling may enable exploiting the inhibition of downstream proteins as therapeutic targets in ATM-mutated PDAC. In English, exciting new ways to fight cancer. https://t.co/mH6P9FRYrN
RT @HenningWillers: #OncoAlert ATM is emerging as a useful marker for #precisiononcology @xrtGenomics @jeremy_setton @TedHong9 https://t.…
RT @HenningWillers: #OncoAlert ATM is emerging as a useful marker for #precisiononcology @xrtGenomics @jeremy_setton @TedHong9 https://t.…
RT @HenningWillers: #OncoAlert ATM is emerging as a useful marker for #precisiononcology @xrtGenomics @jeremy_setton @TedHong9 https://t.…
#OncoAlert ATM is emerging as a useful marker for #precisiononcology @xrtGenomics @jeremy_setton @TedHong9
RT @MPishvaian: This has been a good month for us and I am so proud to share this article on ATM mutations in #PancreaticCancer ATM Dysfu…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
Pancreatic malignancy remains a tumor where incidence exceeds prevalence, excess mortality, and much requires to be understood in this malignancy. Thanks . The SIgA role in pediatric leukemia requires epigenomic modulation understanding for therapeutics!
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @MPishvaian: This has been a good month for us and I am so proud to share this article on ATM mutations in #PancreaticCancer ATM Dysfu…
Somatic mutations in ATM (and other DDR pathway molecules) in pancreatic cancers could represent a vulnerability in this otherwise lethal cancer. I wonder if other therapies that target DNA as part of their MOA could be important here. *cough* #radonc *cou
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
Comprehensive overview on a not uncommon mutation in #PancreaticCancer #PancreaticCancerAwarenessMonth
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @MPishvaian: Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at th…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
RT @Aiims1742: ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely revi…
ATM mutations have emerged as the second most common cause of germline alterations in #PancreaticCancer. A very timely review for #PancreaticCancerAwarenessMonth
RT @MPishvaian: This has been a good month for us and I am so proud to share this article on ATM mutations in #PancreaticCancer ATM Dysfu…
Congratulations to my colleagues @DrSamArmstrong @JonBrodyPhD @MDAndersonnews @Kimmelcancerctr in this effort looking at the role of ATM in #PancreaticCancer ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications https://t.
This has been a good month for us and I am so proud to share this article on ATM mutations in #PancreaticCancer ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications https://t.co/eAMGRs0v3U